# US 2004/0082054 A1 · Novel depsipeptide compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082054 A1
- Document ID: US20040082054A1
- Status: Published application
- Kind: A1
- Application number: 10/684,656
- Filed: 2003-10-15
- Published: 2004-04-29
- Earliest claimed: 1999-01-13
- Assignees: Yamanouchi Pharmaceutical Co., Ltd.
- Inventors: Koji Nagai; Nakako Arao; Kinya Souda; Kazuma Kamigiri; Masamichi Mori; Nobuaki Shindo; Haruo Seto; Kazuo Shin-Ya
- Web page: https://patentgrep.com/patent/US20040082054A1

## CPC

- C07K 5/0205: {containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof}
- A61P 35/00: Antineoplastic agents
- A61K 35/00: Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

This invention relates to a novel compound which has a cytotoxic activity and TGF-β like activity for human cancer cells and is useful as an antitumor agent and to a pharmaceutical composition which contains the same.

## Claims

### Claim 1

A depsipeptide compound represented by the following general formula
3
(wherein r represents isopropyl group, sec-butyl group or isobutyl group) or a pharmaceutically acceptable salt thereof.

### Claim 2 (depends on 1)

A pharmaceutical composition which comprises the depsipeptide compound or a pharmaceutically acceptable salt thereof described in claim 1 as the active ingredient.

### Claim 3 (depends on 2)

The pharmaceutical composition according to claim 2, wherein it is an antitumor agent.
